These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1188783)

  • 1. Proceedings: The anti-thrombotic effect of warfarin, dipyridamole and aspirin in the rat.
    Lavelle SM; MacIomhair M
    Thromb Diath Haemorrh; 1975 Sep; 34(1):343. PubMed ID: 1188783
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition by dipyridamole of arterial thrombosis in rats.
    Didisheim P
    Thromb Diath Haemorrh; 1968 Nov; 20(1):257-66. PubMed ID: 5708896
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of antithrombotic properties of suloctidil in comparison with aspirin and dipyridamole.
    Gurewich V; Lipinski B
    Thromb Res; 1976 Aug; 9(2):101-8. PubMed ID: 968808
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole, and thrombolysis.
    Moschos CB; Lahiri K; Lyons M; Weisse AB; Oldewurtel HA; Regan TJ
    Am Heart J; 1973 Jul; 86(1):61-8. PubMed ID: 4268306
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of low-dose aspirin and dipyridamole upon atherosclerosis in the rabbit.
    Koster JK; Tryka AF; H'Doubler P; Collins JJ
    Artery; 1981; 9(6):405-13. PubMed ID: 7337551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of arterial and venous patency in a rat model of subendothelium-stimulated thrombosis.
    Hupkens P; Cooley BC
    Microsurgery; 1996; 17(4):226-9. PubMed ID: 9140956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; van Vliet HH
    Blood Cells Mol Dis; 2006; 36(2):199-205. PubMed ID: 16510297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications used to prevent adhesion and clotting.
    Lassiter TF
    Lippincotts Prim Care Pract; 2000; 4(6):619-32; quiz 633-5. PubMed ID: 11933375
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of aspirin and dipyridamole on platelet functions in Macaca fascicularis].
    Wang ZG; Po HG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Aug; 5(4):240-5. PubMed ID: 6228318
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus.
    De la Cruz JP; Moreno A; Muñoz M; García Campos JM; Sánchez de la Cuesta F
    J Pharmacol Exp Ther; 1997 Jan; 280(1):454-9. PubMed ID: 8996228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulants.
    Forbes CD; Prentice CR
    Practitioner; 1974 Oct; 213(1276 SPEC NO):470-7. PubMed ID: 4617204
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
    Rosenthal D; Mittenthal MJ; Ruben DM; Jones DH; Estes JW; Stanton PE; Lamis PA
    Am Surg; 1987 Sep; 53(9):477-81. PubMed ID: 3631756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet anti-aggregants as a treatment for thrombotic thrombocytopenic purpura. Apropos of a case].
    Ortiz Monzó F; Sancho García RA; Filgueira Rubio JS; Jiménez Fernández J; Fernández Basave E
    Rev Clin Esp; 1983 May; 169(4):279-81. PubMed ID: 6684782
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight].
    Stormorken H
    Tidsskr Nor Laegeforen; 1971 Feb; 91(6):449-50. PubMed ID: 5546533
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
    Weselcouch EO; Humphrey WR; Aiken JW
    J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.